Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Jessen, F. Articles by Heun, R. Search for Related Content PubMed Citation Articles by Jessen, F. Articles by Heun, R. Geriatric Psychiatry Alzheimer's Disease Symptoms/Dimensions

Sensory Gating Deficit Expressed by a Disturbed Suppression of the P50 Event-Related Potential in Patients With Alzheimer’s Disease

OBJECTIVE: Disturbed sensory gating has been related to attention deficit and greater distractibility in patients with schizophrenia, and dysfunction of the alpha-7 subunit of the cholinergic nicotinic receptor has been discussed as its biological basis. Alzheimer’s disease is characterized by a cholinergic deficit, and postmortem studies have reported alpha-7 receptor loss in patients with Alzheimer’s disease. In this study, the authors tested whether sensory gating is disturbed in patients with Alzheimer’s disease. METHOD: Suppression of the P50 event-related potential following the second click of a double-click paradigm, a measure of sensory gating, was assessed in 17 Alzheimer’s disease patients and 17 comparison subjects. RESULTS: Alzheimer’s disease patients showed less P50 suppression following the second click relative to the comparison subjects. CONCLUSIONS: Disturbed sensory gating might result from cholinergic dysfunction and possibly from alpha-7 nicotinic receptor loss in patients with Alzheimer’s disease. Prospective studies should investigate the relationship between sensory gating deficit and behavioral disturbances in Alzheimer’s disease patients.

This article has been cited by other articles:

				C. A. Yadon, J. M. Bugg, M. A. Kisley, and D. B. Davalos P50 sensory gating is related to performance on select tasks of cognitive inhibition Cogn Affect Behav Neurosci, December 1, 2009; 9(4): 448 - 458. [Abstract] [PDF]

				R. Roncarati, C. Scali, T. A. Comery, S. M. Grauer, S. Aschmi, H. Bothmann, B. Jow, D. Kowal, M. Gianfriddo, C. Kelley, et al. Procognitive and Neuroprotective Activity of a Novel {alpha}7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 459 - 468. [Abstract] [Full Text] [PDF]

				R. S. Bitner, W. H. Bunnelle, D. J. Anderson, C. A. Briggs, J. Buccafusco, P. Curzon, M. W. Decker, J. M. Frost, J. H. Gronlien, E. Gubbins, et al. Broad-Spectrum Efficacy across Cognitive Domains by {alpha}7 Nicotinic Acetylcholine Receptor Agonism Correlates with Activation of ERK1/2 and CREB Phosphorylation Pathways J. Neurosci., September 26, 2007; 27(39): 10578 - 10587. [Abstract] [Full Text] [PDF]

				B. A. Ally, G. E. Jones, J. A. Cole, and A. E. Budson Sensory Gating in Patients With Alzheimer's Disease and Their Biological Children American Journal of Alzheimer's Disease and Other Dementias, January 1, 2007; 21(6): 439 - 447. [Abstract] [PDF]

				R.-P. Behrendt Dysregulation of thalamic sensory 'transmission' in schizophrenia: neurochemical vulnerability to hallucinations J Psychopharmacol, May 1, 2006; 20(3): 356 - 372. [Abstract] [PDF]

				R. J. Thoma, F. M. Hanlon, S. N. Moses, J. C. Edgar, M. Huang, M. P. Weisend, J. Irwin, A. Sherwood, K. Paulson, J. Bustillo, et al. Lateralization of Auditory Sensory Gating and Neuropsychological Dysfunction in Schizophrenia Am J Psychiatry, September 1, 2003; 160(9): 1595 - 1605. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us